Takeaways

#
  • Zaccardi saw improving participation and buying during the trading day as support for the November rally.
  • He expected year-end performance chasing to favor existing leaders, while watching for later changes.
  • Zaccardi was watching retail, biotech and regional banks for possible strength around the turn of the year.
  • The discussion emphasized reassessing leadership near year-end instead of assuming the current winners would keep leading.

A strong November rally gave investors a reason to keep following the winners. Mike Zaccardi was also thinking about what might happen when that year-end chase ended.

On the November 17, 2023 Morning Show, he described a constructive market with improving participation from small caps and overseas stocks. He expected the leading stocks to remain attractive into year-end, while preparing a watchlist of groups that could recover as the calendar turned.

The rally had support beyond the largest stocks

Zaccardi welcomed the broader participation and recent breadth thrusts. He also pointed to repeated sessions in which stocks closed above their opening prices, interpreting that buying during the day as a bullish sign.

The rebound had arrived as the calendar moved into November, following an oversold period. He thought some of the strength normally associated with the season might already have occurred. Thanksgiving week still looked favorable to him, but he acknowledged that each year could develop differently.

His broader point was to stay alert at year-end. He recalled the shift away from technology entering 2022 and the reversal of that leadership pattern entering 2023. Active investors, he argued, should use the period to reconsider what prices were showing.

Retail, biotech and banks were potential next leaders

Zaccardi expected performance chasing to favor the existing winners first. As the year drew to a close, he wanted regional banks, retailers and biotechnology stocks on the radar.

He specifically mentioned the SPDR S&P Retail ETF, XRT, and discussed equal-weighted funds with the hosts, including the SPDR S&P Biotech ETF, XBI. The idea was to watch groups that had been left behind and could respond to a change in conditions.

Retail earnings illustrated how low expectations could affect a stock’s response. Zaccardi said beaten-down names could attract buyers on even modestly encouraging news. The hosts compared those reactions with stocks that had entered earnings carrying higher expectations.

He also considered regional banks in the context of a potentially steepening yield curve and saw insurance shares as another area of financial strength. Small caps’ sharp rebound that week could, in his view, encourage investors to buy subsequent pullbacks.

JC Parets shared the interest in year-end reversals, particularly when an extended trend persisted into the quieter late-December period.

Questions and answers

#

Questions answered in the original 2023-11-17 episode.

What supported Zaccardi’s constructive market view?

He pointed to participation from small caps and overseas stocks, recent breadth thrusts and repeated sessions with buying from the open to the close.

Link to this answer

Which groups was he watching for a recovery?

He highlighted regional banks, retailers and biotechnology stocks as possible areas of renewed strength around the turn of the year. He also noted strength in insurance shares.

Link to this answer

Why did Zaccardi see opportunities in beaten-down retailers?

He said modestly encouraging news could bring buyers into stocks with low expectations. The hosts contrasted that with companies whose shares already reflected more optimism before earnings.

Link to this answer

Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .